Current and Future Applications of Gene Therapy in Respiratory Disease *

Blaese RM , Culver KW , Miller AD . T lymphocyte-directed gene therapy for ADA-SCID: Initial trial results after 4 years. Science 1995; 270:475–80.

Alton EW , Geddes DM . Prospects for gene therapy. Br J Hosp Med 1997; 58:47–9.

Crystal RG . Transfer of genes to humans: early lessons and obstacles to success. Science 1995; 270:404–10.

Verma IM , Somia N . Gene therapy - promises, problems and prospects. Nature 1997; 389:239–42.

Weatherall DJ . Scope and limitations of gene therapy. Br Med Bull 1995; 51:1–11.

Marcel T , Grausz JD . The TMC worldwide gene therapy enrollment report, end 1996. Human Gene Therapy 1997; 8:775–800.

Curiel DT , Pilewski JM , Albelda SM . Gene therapy approaches for inherited and acquired lung diseases. Am J Respir Cell Mol Biol 1996; 14:1–18.

Schofield JP , Caskey CT . Non-viral approaches to gene therapy. Br Med Bull 1995; 51:56–71.

Alton EWFW , Geddes DM , Gill DR . Towards gene therapy for cystic fibrosis: a clinical progress report. Gene Therapy 1998; 5:291–2.

Mulligan RC . The basic science of gene therapy. Science 1993; 260:926–32.

Snyder RO , Miao CH , Patijn GA . Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nature Genetics 1997; 16:270–6.

Goins WF , Krisky D , Marconi P . Herpes simplex virus vectors for gene transfer to the nervous system. J Neurovirology 1997; 3(Suppl 1):S80–S88.

Miller AD . Retroviral vectors. Curr Topics Microbiol Immunol 1992; 158:1–24.

Miyanohara A , Abi A , Friedmann T . Partial cell-free assembly of VSV-G pseudotyped retrovirus particles. Keystone Symposia: Molecular and Cellular Biology of Gene Therapy 1998; J7:34.

Kremer EJ , Perricaudet M . Adenovirus and adeno-associated virus mediated gene transfer. Br Med Bull 1995; 51:31–44.

Sallenave J-M , Xing Z , Simpson AJ . Adenovirus-mediated expression of an elastase-specific inhibitor (elafin): a comparison of different promoters. Gene Therapy 1998; 5:352–60.

Bett AJ , Haddara W , Prevec L , Graham FL . An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc Natl Acad Sci USA 1994; 91:8802–6.

Van Ginkel FW , Liu C , Simecka JW . Intratracheal gene delivery with adenoviral vector induces elevated systemic IgG and mucosal IgA antibodies to adenovirus and β-galactosidase. Human Gene Therapy 1995; 6:895–903.

Kaplan JM , St George JA , Pennington SE . Humoral and cellular immune responses of nonhuman primates to long-term repeated lung exposure to Ad2/CFTR-2. Gene Therapy 1996; 3:117–27.

Yang Y , Nunes FA , Berencsi K . Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 1994; 91:4407–11.

Kaplan JM , Armentano D , Sparer TE . Characterization of factors involved in modulating persistence of transgene expression from recombinant adenovirus in the mouse lung. Human Gene Therapy 1997; 8:45–56.

Song W , Kong H-L , Traktman P , Crystal RG . Cytotoxic T lymphocyte responses to proteins encoded by heterologous transgenes transferred in vivo by adenoviral vectors. Human Gene Therapy 1997; 8:1207–17.

Yei S , Mittereder N , Tang K . Adenovirus-mediated gene transfer for cystic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lung. Gene Therapy 1994; 1:192–200.

Worgall S , Wolff G , Falck-Pedersen E , Crystal RG . Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Human Gene Therapy 1997; 8:37–44.

Worgall S , Leopold PL , Wolff G . Role of alveolar macrophages in rapid elimination of adenovirus vectors administered to the epithelial surface of the respiratory tract. Human Gene Therapy 1997; 8:1675–84.

Wersto RP , Rosenthal ER , Seth PK . Recombinant, replication-deficient adenovirus gene transfer vectors induce cell cycle dysregulation and inappropriate expression of cyclin proteins. J Virol 1998; 72:9491–502.

Hierholzer J . Adenoviruses in the immunocompromised host. Clin Microbiol Rev 1992; 5:262–74.

Rosenecker J , Harms KH , Bertele RM . Adenovirus infection in cystic fibrosis patients: implications for the use of adenoviral vectors for gene transfer. Infection 1996; 24:5–8.

Elliott WM , Hayashi S , Hogg JC . Immunodetection of adenoviral E1A proteins in human lung tissue. Am J Respir Cell Mol Biol 1995; 12:642–8.

Fallaux FJ , van der Eb AJ , Hoeben RC . Who's afraid of replication-competent adenoviruses? Gene Therapy 1999; 6:709–12.

Davis PB , Drumm M , Konstan MW . Cystic fibrosis. Am J Respir Crit Care Med 1996; 154:1229–56.

Geddes DM . Cystic fibrosis: epidemiology and pathogenesis. In: Brewis RAL , Gibson GJ , Geddes DM , eds Respiratory medicine London: Baillière Tindall, 1990; 760–9.

Rommens JM , Iannuzzi MC , Kerem B . Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 1989; 245:1059–65.

Grubb BR , Boucher RC . Pathophysiology of gene-targeted mouse models for cystic fibrosis. Physiol Rev 1999; 79:S193–S214.

Kent G , Iles R , Bear CE . Lung disease in mice with cystic fibrosis. J Clin Invest 1997; 100:3060–9.

Davidson DJ , Dorin JR , McLachlan G . Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens. Nature Genetics 1995; 9:351–7.

Zabner J , Couture LA , Gregory RJ . Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 1993; 75:207–16.

Zabner J , Ramsey BW , Meeker DP . Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis. J Clin Invest 1996; 97:1504–11.

Hay JG , McElvaney NG , Herena J . Modification of nasal epithelial potential differences of individuals with cystic fibrosis consequent to local administration of a normal CFTR cDNA adenovirus gene transfer vector. Human Gene Therapy 1995; 6:1487–96.

Knowles MR , Hohneker KW , Zhou Z . A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N Eng J Med 1995; 333:823–31.

Crystal RG , McElvaney NG , Rosenfeld MA . Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nature Genetics 1994; 8:42–51.

Bellon G , Michel-Calemard L , Thouvent D . Aerosol administration of a recombinant adenovirus expressing CFTR to cystic fibrosis patients: a phase I clinical trial. Human Gene Therapy 1997; 8:15–25.

Caplen NJ , Alton E , Middleton PG . Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nature Medicine 1995; 1:39–46.

Porteous DJ , Dorin JR , McLachlan G . Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Therapy 1997; 4:210–18.

Gill DR , Southern KW , Mofford KA . A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Therapy 1997; 4:199–209.

Alton EWFW , Stern M , Farley R . Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet1999; 353:947–54.

Wagner JA, Reynolds T, Moran ML et al. Efficient and persistent gene transfer of AAV-CFTR in maxillary sinus. Lancet 1998; 351:1702–3.

Flotte T , Poirier A , Wang J . Excessive levels of neutrophil elastase and neutrophil defensin in cystic fibrosis BAL fluid inhibit rAAV transduction. Am J Respir Crit Care Med 1999; 159:A433.

Jiang C , Finkbeiner WE , Widdicombe JH . Restoration of cyclic adenosine monophosphate stimulated chloride channel activity in human tracheobronchial submucosal gland cells by adenovirus-mediated and cationic lipid-mediated gene transfer. Am J Respir Cell Mol Biol 1999; 20:1107–15.

Pickles RJ , Barker PM , Ye H , Boucher RC . Efficient adenovirus-mediated gene transfer to basal but not columnar cells of cartilaginous airway epithelia. Human Gene Therapy 1996; 7:921–31.

Dorin JR , Farley R , Webb S . A demonstration using mouse models that successful gene therapy for cystic fibrosis requires only partial gene correction. GeneTherapy 1996; 3:797–801.

Laurell CB , Eriksson S . The electrophoretic α1-globulin pattern of serum in α1-antitrypsin deficiency. Scand J Clin Lab Invest1963; 15:132–40.

Hutchison DCS . Chronic obstructive pulmonary disease (COPD): Proteases and antiproteases. In: Brewis RAL , Gibson GJ , Geddes DM (eds). Respiratory medicine London: Baillière Tindall,, 1990;485–96.

Stoller JK . Clinical features and natural history of severe α1-antitrypsin deficiency. Chest 1997; 111:123S-128S.

Gadek JE , Fells GA , Zimmerman RL . Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema. J Clin Invest 1981; 68:889–98.

Alton EWFW , Geddes DM . Gene therapy for respiratory diseases: potential applications and difficulties. Thorax 1995; 50:484–6.

Baumgartner I , Pieczek A , Manor O . Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 1998; 97:1114–23.

Rosenfeld MA , Siegfried W , Yoshimura K . Adenovirus-mediated transfer of a recombinant α1-antitrypsin gene to the lung epithelium in vivo. Science 1991; 252:431–4.

Canonico AE , Conary JT , Meyrick BO , Brigham KL . Aerosol and intravenous transfection of human α1-antitrypsin gene to lungs of rabbits. Am J Respir Cell Mol Biol 1994; 10:24–9.

Spiro SG . Tumours: lung tumours. In: Brewis RAL , Gibson GJ , Geddes DM (eds). Respiratory medicine London: Baillière Tindall,, 1990;832–79.

Albelda SM . Gene therapy for lung cancer and mesothelioma. Chest 1997; 111:144S-149S.

Tsurz T , Cesne AL , Baldeyrou P . Phase I study of a recombinant adenovirus-mediated gene transfer in lung cancer patients. J Natl Cancer Inst 1996; 88:1857–63.

Gahery-Segard H , Molinger-Frenkel V , Le Boulaire C . Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral products. J Clin Invest 1997; 100:2218–26.

Gazzeri S , Bramilla E , Caron de Fromentel C . p53 genetic abnormalities and myc activation in human lung carcinoma. Int J Cancer 1994; 58:24–32.

Roth JA , Nguyen D , Lawrence DD . Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nature Medicine 1996; 2:985–91.

Roth JA , Swisher SG , Merritt JA . Gene therapy for non-small cell lung cancer: a preliminary report of a phase I trial of adenoviral p53 gene replacement. Semin Oncol 1998; 25 (Suppl 8):33–7.

Schuler M , Rochlitz C , Horowitz JA . A phase I study of adenovirus-mediated wild-type p53 gene transfer in patients with advanced non-small cell lung cancer. Human Gene Therapy 1998; 9:2075–82.

Tan Y , Xu M , Wang W . IL-2 gene therapy of advanced lung cancer patients. Anticancer Res 1996; 16(4A):1993–8.

Heo DS , Yoon SJ , Kim WS . Locoregional response and increased natural killer activity after intratumoral injection of HLA-B7/beta2-microglobulin gene in patients with cancer. Human Gene Therapy 1998; 9:2031–38.

Webb A , Cunningham D , Cotter F . BCL-2 antisense therapy in patients with non-Hodgkin lymphoma. Lancet 1997; 349:1137–41.

Rudd RM . Asbestos-related disease. In: Brewis RAL , Gibson GJ , Geddes DM (eds). Respiratory medicine London: Baillière Tindall,, 1990;1241–65.

Peto J , Hodgson JT , Matthews FE , Jones JR . Continuing increase in mesothelioma mortality in Britain. Lancet 1995; 345:535–9.

Hwang HC , Smythe WR , Elshami AA . Gene therapy using adenovirus carrying the herpes simplex-thymidine kinase gene to treat in vivo models of human malignant mesothelioma and lung cancer. Am J Respir Cell Mol Biol 1995; 13:7–16.

Tiberghien P . Use of suicide genes in gene therapy. J Leukocyte Biol 1994; 56:203–9.

Dilber MS , Smith CIE . Suicide genes and bystander killing: local and distant effects. Gene Therapy 1997; 4:273–4.

Sterman DH , Treat J , Litzky LA . Adenovirus-mediated herpes simplex virus thymidine kinase/gancyclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma. Human Gene Therapy 1998; 9:1083–92.

Molnar-Kimber KL , Sterman DH , Chang M . Impact of preexisting and induced humoral and cellular immune responses in an adenovirus-based gene therapy phase I clinical trial for localized mesothelioma. Human Gene Therapy 1998; 9:2121–33.

Schwarzenberger P , Harrison L , Weinacker A . The treatment of malignant mesothelioma with a gene modified cancer cell line: a phase I study. Human Gene Therapy 1998; 9:2641–9.

Schwarzenberger P , Lei D , Freeman SM . Antitumor activity with the HSV-tk-gene-modified cell line PA-1-STK in malignant mesothelioma. Am J Respir Cell Mol Biol 1998; 19:333–7.

Kolls JK , Lei D , Nelson S . Adenoviral-mediated murine interferon gene transfer compartmentally activates alveolar macrophages and enhances bacterial clearance. Chest 1997; 111:104S.

Kolls JK , Habetz S , Vazquez C . Interferon-? and CD8+ T-cells restore host defences against P.carinii in mice depleted of CD4+ T-cells. J Immunol 1999; 162:2890–4.

Greenberger MJ , Kunkel SL , Strieter RM . IL-12 gene therapy protects mice in lethal Klebsiella pneumonia. J Immunol1996; 157:3006–12.

Dickler HB , Collier E. Vaccines: new approaches and concepts. J Allergy Clin Immunol 1997; 97:896–906.

84 Tascon RE , Colston MJ , Ragno S . Vaccination against tuberculosis by DNA injection. Nature Medicine 1996; 2:888–92.

Huygen K , Content J , Denis O . Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nature Medicine1996; 2:893–8.

Trulock RP . Lung transplantation. Am J Respir Crit Care Med 1997; 155:789–818.

Chapelier A , Danel C , Mazmanian M . Gene therapy in lung transplantation: feasibility of ex vivo adenovirus-mediated gene transfer to the graft. Human Gene Therapy 1996; 7:1837–45.

Yang L , Lochmuller H , Luo J . Adenovirus-mediated dystrophin minigene transfer improves muscle strength in adult dystrophic (MDX) mice. Gene Therapy 1998; 5:369–79.

Petrof BJ . Respiratory muscles as a target for adenovirus mediated gene therapy. Eur Respir J 1998; 11:492–7.

Sime PJ , Xing Z , Graham FL . Adenovector-mediated gene transfer of active transforming growth factor-beta 1 induces prolonged severe fibrosis in rat lung. J Clin Invest 1999; 100:768–76.

Sallenave J-M , Morgan K , Gauldie J , Kalsheker N . Elastase inhibitors in the lung: expression and functional relationships. In: Stockley RA . Molecular biology of the lung Vol 1: Emphysema and infection Basel: Birkhäuser Verlag,, 1999;69–94.

Sallenave J-M , Silva A . Characterization and gene sequence of the precursor of elafin, an elastase-specific inhibitor in bronchial secretions. Am J Respir Cell Mol Biol 1993; 8:439–45.

Sallenave J-M , Shulmann J , Crossley J . Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes. Am J Respir Cell Mol Biol 1994; 11:733–41.

Simpson AJ , Porteous DJ , Haslett C , Sallenave J-M . Pulmonary epithelial cells transfected with E1-deleted adenovirus encoding human elafin cDNA are protected against neutrophil elastase. Am J Respir Crit Care Med 1999; 159:A239.

Simpson AJ , Antonicelli F , Haslett C , Sallenave J-M . Differential LPS-induced elafin release from macrophages treated with or without E1-deleted adenovirus encoding human elafin cDNA. Am J Respir Crit Care Med 1999; 159:A193.

Hiemstra PS , Maassen RJ , Stolk J . Antibacterial activity of antileukoprotease. Infect Immun 1996; 64:4520–4.

McNeely TB , Dealy M , Dripps DJ . Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. J Clin Invest 1995; 96:456–64.

Jin F-Y , Nathan C , Radzioch D , Ding A . Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell 1997; 88:417–26.

Simpson AJ , Maxwell AI , Govan JRW . Elafin (elastase specific inhibitor) has antimicrobial activity against Gram positive and Gram negative respiratory pathogens. FEBS Lett 1999; 452:309–13.

Dorin JR , Porteous DJ . Cystic fibrosis mice with disease related changes in lung and reproductive tracts. Lancet 1992; 340:984.

Lamb JR , Tsitoura DC , Hoyne GF . Peptide mediated modulation of allergen specific immune responses. Arb Paul Ehrlich Inst Bundesamt Sera Impstoffe Frankf A M 1997; 91:14–20.

Bergelson JM , Cunningham JA , Droguett G . Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997; 275:1320–3.

Qing K , Mah C , Hansen J . Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno associated virus 2. Nature Medicine 1999; 5:71–7.

Summerford C , Bartlett JS , Samulski RJ . αVβ5 integrin: a co receptor for adeno-associated virus type 2 infection. Nature Medicine 1999; 5:78–82.

Rogers BE , Douglas JT , Ahlem C . Use of a novel cross linking method to modify adenoviral tropism. Gene Therapy 1997; 4:1387–92.

Dmitriev I , Krasnykh V , Miller CR . An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism. J Virol 1998; 72:9706–13.

Glasser SW , Korfhagen TR , Wert SE , Whitsett JA . Transgenic models for study of pulmonary development and disease. Am J Physiol 1994; 267 (Lung Cell Mol Physiol 11): L489–L497.

Strayer MS , Guttentag SH , Ballard PL . Targeting type II and Clara cells for adenovirus-mediated gene transfer using the surfactant protein B promoter. Am J Respir Cell Mol Biol 1998; 18:1–11.

Kistner A , Gossen M , Zimmermann F . Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci USA 1996; 93:10933–8.

No D , Yao T-P , Evans RM . Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc Natl Acad Sci USA 1996; 93:3346–51.

Parks RJ , Chen L , Anton U . A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal. Proc Natl Acad Sci USA 1996; 93:13565–70.

Fisher KJ , Choi H , Burda J . Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. Virology 1996; 217:11–22.

Mitani K , Graham FL , Caskey CT , Kochanek S . Rescue, propagation, and partial purification of a helper virus-dependent adenovirus vector. Proc Natl Acad Sci USA 1995; 92:3854–8.

Scheidner G , Morral N , Parks RJ . Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nature Genetics 1998; 18:180–3.

Yang Y , Trinchieri G , Wilson JM . Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nature Medicine 1995; 1:890–3.

Wilson C , Kay MA . Immunomodulation to enhance gene therapy. Nature Medicine 1995; 1:887–9.

Wilson CB , Embree LJ , Schowalter D . Transient inhibition of CD28 and CD40 ligand interactions prolongs adenovirus-mediated transgene expression in the lung and facilitates expression after secondary vector administration. J Virol 1998; 72:7542–50.

Zsengellér ZK , Boivin GP , Sawchuk SS . Anti-T cell receptor antibody prolongs transgene expression and reduces lung inflammation after adenovirus-mediated gene transfer. Human Gene Therapy 1997; 8:935–41.

Ilan Y , Prakash R , Davidson A . Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors. J Clin Invest 1997; 99:1098–106.

Schowalter DB , Tubb JC , Liu M . Heterologous expression of adenovirus E3-gp19k in an E1a-deleted adenovirus vector inhibits MHC 1 expression in vitro, but does not prolong transgene expression in vivo. Gene Therapy 1997; 4:351–60.

Chirmule N , Hughes JV , Gao G-P . Role of E4 in eliciting CD4 T-cell and B-cell responses to adenovirus vectors delivered to murine and nonhuman primate lungs. J Virol 1998; 72:6138–45.

Vilquin J-T , Guérette B , Kinoshita I . FK506 immunosuppression to control the immune reactions triggered by first-generation adenovirus-mediated gene transfer. Human Gene Therapy 1995; 6:1391–401.

Kaplan JM , Smith AE . Transient immunosuppression with deoxyspergualin improves longevity of transgene expression and ability to readminister adenoviral vector to the mouse lung. Human Gene Therapy 1997; 8:1095–104.

Jooss K , Turka LA , Wilson JM . Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig. Gene Therapy 1998; 5:309–19.

Mack CA , Song W-R , Carpenter H . Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype. Human Gene Therapy 1997; 8:99–109.

Larson JE , Morrow SL , Happei L . Reversal of cystic fibrosis phenotype in mice by gene therapy in utero. Lancet 1997; 349:619–20.